Naclof (Diclofenac Sodium)

Diclofenac sodium inhibits cyclooxygenase enzymes (COX‑1 and COX‑2) in ocular tissues, decreasing the production of prostaglandins that drive inflammation and pain. By lowering these mediators, the drug reduces swelling, redness, and discomfort in the treated eye.

The dosing regimen for Naclof is determined by the prescribing eye care professional based on the specific condition, severity, and patient factors. The prescriber will specify the number of drops, frequency, and duration of treatment.

Safety of ocular diclofenac during pregnancy or lactation has not been fully established. It should be used only if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made in consultation with a healthcare provider.

To order Naclof, submit an enquiry on the product page at gnhindia.com indicating the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Naclof (diclofenac) is a non‑steroidal anti‑inflammatory drug, offering anti‑inflammatory and analgesic effects without the steroid‑related rise in intra‑ocular pressure. Compared with corticosteroid eye drops, it has a lower risk of steroid‑induced glaucoma but may carry a higher risk of corneal irritation when used long‑term.

Store Naclof at room temperature, preferably below 25 °C, in its original packaging. Protect the container from excessive light, moisture, and heat. Ensure the cap is tightly closed to maintain sterility.

Naclof is applied as an ophthalmic solution. The prescribed number of drops is placed into the lower conjunctival sac of the affected eye(s) using the provided dropper, typically without touching the eye or eyelid. Follow the prescriber’s instructions for frequency and duration.

Serious risks include corneal ulceration or perforation, severe allergic reactions such as angioedema, Stevens‑Johnson syndrome, and significant vision loss. Patients should seek immediate medical attention if they experience persistent pain, worsening vision, or signs of severe eye irritation.

Naclof should not be used by individuals with known hypersensitivity to diclofenac, other NSAIDs, or any component of the formulation. It is also contraindicated in patients with active ocular infections, corneal ulcers, or those using other ocular NSAID products without medical supervision.